Instil Bio, Inc. SEC filings TIL
Instil Bio, Inc. has 248 filings in SEC EDGAR's recent list, going back to Sep 30, 2019. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFR14A | Filing | May 2, 2025 | — |
| EFFECT | Filing | Nov 21, 2024 | — |
| CORRESP | Letter to the SEC | Nov 19, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2024 | — |
| DEFR14A | Filing | Apr 28, 2023 | — |
| EFFECT | Filing | Mar 18, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 18, 2021 | — |
| CERT | 8a cert | Mar 18, 2021 | — |
| CORRESP | Letter to the SEC | Mar 16, 2021 | — |
| CORRESP | Letter to the SEC | Mar 16, 2021 | — |
| 8-A12B | Filing | Mar 15, 2021 | — |
| CORRESP | Letter to the SEC | Mar 15, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 8, 2021 | — |
| CORRESP | Letter to the SEC | Mar 8, 2021 | — |
| CORRESP | Letter to the SEC | Feb 26, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 24, 2021 | — |
| D | Filing | Feb 23, 2021 | — |
| DRSLTR | Filing | Feb 12, 2021 | — |
| DRS/A | Filing | Feb 12, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2021 | — |
| DRS | Filing | Jan 12, 2021 | — |
| D | Filing | Aug 5, 2020 | — |
| D | Filing | Aug 5, 2020 | — |
| D/A | Filing | Aug 5, 2020 | — |
| D | Filing | Sep 30, 2019 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TIL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NY
- Headquarters
- Dallas, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1789769
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.